Improving nelarabine efficacy in T cell acute lymphoblastic leukemia by targeting aberrant PI3K/AKT/mTOR signaling pathway

by Lonetti, Annalisa, Cappellini, Alessandra, Bertaina, Alice, Locatelli, Franco, Pession, Andrea, Buontempo, Francesca, Evangelisti, Camilla, Evangelisti, Cecilia, Orsini, Ester, Zambonin, Laura, Neri, Luca Maria, Martelli, Alberto Maria, Chiarini, Francesca
Published 2016

Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apo...

by Buontempo, Francesca, Orsini, Ester, Lonetti, Annalisa, Cappellini, Alessandra, Chiarini, Francesca, Evangelisti, Camilla, Evangelisti, Cecilia, Melchionda, Fraia, Pession, Andrea, Bertaina, Alice, Locatelli, Franco, Bertacchini, Jessika, Neri, Luca Maria, McCubrey, James A., Martelli, Alberto Maria
Published 2015

eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study

by Gardini, Andrea Casadei, Marisi, Giorgia, Faloppi, Luca, Scarpi, Emanuela, Foschi, Francesco Giuseppe, Iavarone, Massimo, Lauletta, Gianfranco, Corbelli, Jody, Valgiusti, Martina, Facchetti, Floriana, Corte, Cristina della, Neri, Luca Maria, Tamberi, Stefano, Cascinu, Stefano, Scartozzi, Mario, Amadori, Dino, Nanni, Oriana, Tenti, Elena, Ulivi, Paola, Frassineti, Giovanni Luca
Published 2016